NCT02848625

Brief Summary

This study will evaluate whether regular yoga exercises designed specifically for patients with Idiopathic Pulmonary Fibrosis is associated with any change in quality of life. Half of the participants will be randomized to yoga, half to usual care. Yoga was conducted live, virtually, in the setting of the COVID Pandemic.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 28, 2016

Completed
4.5 years until next milestone

Study Start

First participant enrolled

January 27, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

4.9 years

First QC Date

July 26, 2016

Last Update Submit

January 28, 2025

Conditions

Idiopathic Pulmonary Fibrosis

Keywords

Idiopathic Pulmonary FibrosisYogaQuality of life

Outcome Measures

Primary Outcomes (1)

  • Quality of life

    12 weeks

Secondary Outcomes (2)

  • change in forced vital capacity

    12 weeks

  • change in 6 minute walk distance

    12 weeks

Study Arms (2)

Group A

EXPERIMENTAL

Patients randomized to 12 weeks of twice weekly yoga sessions. The yoga exercises have been designed specifically for patients with IPF. Yoga sessions were virtual in the setting of the COVID Pandemic

Other: Yoga

Group B

NO INTERVENTION

Patients who are not randomized to yoga sessions will continue with their usual care and usual activities

Interventions

YogaOTHER

Yoga and breathing exercises designed for patients with IPF. Sessions will be two times per week for 12 weeks

Group A

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington Medical Center

Seattle, Washington, 98195, United States

Location

MeSH Terms

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

Yoga

Condition Hierarchy (Ancestors)

Pulmonary FibrosisLung Diseases, InterstitialLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Ganesh Raghu, MD

    University of Washington, Center for Interstitial Lung Diseases

    PRINCIPAL INVESTIGATOR

  • Bridget F Collins, MD

    University of Washington, Center for Interstitial Lung Diseases

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Principal Investigator (Ganesh Raghu, MD is Principal Investigator)

Study Record Dates

First Submitted

July 26, 2016

First Posted

July 28, 2016

Study Start

January 27, 2021

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 31, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations

US(1)